Literature DB >> 34344146

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management.

Jihye Park1, Sinyoung Park2, Shin Ae Lee1, Soo Jung Park1, Jae Hee Cheon1.   

Abstract

The incidence and prevalence rates of inf lammatory bowel disease (IBD) have been increasing in East Asian countries over the past few decades. Accordingly, the general understanding and awareness of IBD among healthcare professionals has increased considerably in this region. This increase is ultimately associated with the evolving focus of IBD clinicians devoted to comprehensive patient care, especially in establishing IBD clinics/centers capable of providing multidisciplinary counseling. Comprehensive IBD care at IBD clinics/centers usually includes surgical and medication decision-making, transition from pediatric to adult clinics, care of extraintestinal manifestations, care of infectious diseases in patients undergoing immunomodulatory or biologic therapies, and nutritional, psychosocial, socioeconomic, and pharmacological care. Team members comprise specialists from various departments related to IBD and can be divided into core and ad hoc members. Usually, the scope of work in IBD clinics/centers involves patient care, patient outreach, and system management. Considering the environmental changes in IBD treatment, it is necessary to perform comprehensive IBD patient care in the form of a program based on competencies, rather than simply following the organization of previous IBD centers. The present review summarizes recent trends in IBD patient care and offers perspectives regarding IBD center management.

Entities:  

Keywords:  Inflammatory bowel diseases; Interdisciplinary communication; Progressive patient care

Year:  2021        PMID: 34344146     DOI: 10.3904/kjim.2021.114

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  4 in total

1.  Ulcerative Colitis and Patient's Quality of Life, Especially in Early Stage.

Authors:  Jung Won Lee
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

Review 2.  Inflammatory bowel disease in Korea: epidemiology and pathophysiology.

Authors:  Jung Won Lee; Chang Soo Eun
Journal:  Korean J Intern Med       Date:  2022-07-29       Impact factor: 3.165

Review 3.  Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α.

Authors:  Jihye Park; Jae Hee Cheon
Journal:  Korean J Intern Med       Date:  2022-07-27       Impact factor: 3.165

4.  Correlation of Serum CA242, CA724, and TPA Levels with Clinicopathological Features and Prognosis in Patients with Inflammatory Bowel Disease Complicated with Rectal Cancer.

Authors:  Hongliang Liang; Xi Yang
Journal:  J Oncol       Date:  2022-09-19       Impact factor: 4.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.